Notably, 18F-flortaucipir presents higher affinity to “AD-like” tau aggregates than that in other neurodegenerative tauopathies, while it should be noticed that the sensitivity of 18F-flortaucipir might not be enough to diagnose early stage of AD, such as Braak stage 0. The gene discussed is MAPT; the disease is Alzheimer disease.